Ipamorelin
Mass not specified- Sequence / identity
- Aib-His-D-2-Nal-D-Phe-Lys-NH2
- CAS number
- 170851-70-4
● In stockCOA on request ↗
Ipamorelin/ Tesamorelin
Cat. No. IPTESA | Mass per vial on the lot certificate | Blend
$84.99per vial
Bundle & save
$84.99 / vial at this quantity
Orders submitted before 2 PM ET dispatch the same business day after approval and payment confirmation. U.S. shipping is $15 per order, free on orders of $250 or more.
- Lab testedISO/IEC 17025 lab
- Made in the USALyophilized in the U.S.
- Same business dayFree U.S. shipping at $250
Quantity savings are applied automatically. Retail orders allow up to 10 vials per product.
Lab results
ISO/IEC 17025-accredited lab- Endotoxin threshold
- ✓ Pass
- Microbial analysis (PCR)
- ✓ Pass
- Purity
- >99%Premium grade
Applies to our peptide products. Request your batch-specific report →
Product details
Two-component research blend supplied as a single lyophilized aliquot containing Ipamorelin and Tesamorelin. Per-component mass is confirmed on the certificate of analysis for the lot supplied.
Research use only. Not for human or animal use.
Specifications
| Form | Lyophilized powder |
|---|
BLEND Composition
Component amounts per vial.
Tesamorelin
Mass not specifiedScientific references Optional background reading
| Synonyms | Ipa & Tesa Blend |
|---|
A mixture does not have one molecular structure or one molar mass. The viewer identifies individual reference components, and the literature cards describe research on those components separately.
Mechanism under investigation
Research on ipamorelin and tesamorelin examines different molecular and cellular systems. No combined mechanism or interaction is established by placing these compounds in one vial. The selected references are component-level context, not studies of this blend.
Selected literature
Cell assays · animal models
Profiling ipamorelin receptor selectivity
The authors profiled ipamorelin using receptor antagonists and hormone measurements. This reference concerns ipamorelin individually and does not test an ipamorelin–tesamorelin blend.
Raun K et al. · Eur J Endocrinol · 1998 · PMID 9849822Human research study
Characterizing endogenous hormone pulsatility
This small study examined endogenous growth-hormone pulse patterns and insulin sensitivity during exposure to a GHRH analogue. Its study formulation is distinct from this laboratory catalog material.
Stanley TL et al. · J Clin Endocrinol Metab · 2011 · PMID 20943777These publications describe their own experimental materials and models, not testing of this product. Research-use policy →
Also in the catalog
